Merit Financial Group LLC cut its stake in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 32.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 75,266 shares of the semiconductor company's stock after selling 36,870 shares during the period. Merit Financial Group LLC's holdings in Lam Research were worth $32,615,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of LRCX. Bayban acquired a new stake in Lam Research in the 4th quarter valued at about $26,000. Vermillion Wealth Management Inc. acquired a new position in shares of Lam Research during the first quarter worth about $26,000. Cedar Mountain Advisors LLC grew its position in shares of Lam Research by 242.9% during the first quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company's stock worth $26,000 after buying an additional 85 shares in the last quarter. Mcguire Capital Advisors Inc. purchased a new stake in shares of Lam Research during the fourth quarter worth approximately $27,000. Finally, Triumph Capital Management purchased a new stake in shares of Lam Research during the third quarter worth approximately $27,000. 84.61% of the stock is owned by institutional investors and hedge funds.
Insider Activity at Lam Research
In other Lam Research news, Director Abhijit Y. Talwalkar sold 18,282 shares of the business's stock in a transaction that occurred on Monday, July 13th. The stock was sold at an average price of $335.00, for a total value of $6,124,470.00. Following the completion of the sale, the director owned 87,142 shares in the company, valued at approximately $29,192,570. The trade was a 17.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total value of $19,118,600.00. Following the completion of the sale, the director directly owned 199,205 shares of the company's stock, valued at $69,881,114. The trade was a 21.48% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 80,441 shares of company stock valued at $27,614,296 in the last three months. 0.31% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on the stock. Oppenheimer reiterated an "outperform" rating and issued a $400.00 price target (up from $330.00) on shares of Lam Research in a research note on Monday, June 15th. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a $320.00 price target on shares of Lam Research in a report on Thursday, July 30th. BNP Paribas Exane upped their price objective on Lam Research from $250.00 to $260.00 and gave the stock a "neutral" rating in a research report on Thursday, April 23rd. Susquehanna reiterated a "positive" rating and issued a $475.00 price objective (up from $385.00) on shares of Lam Research in a report on Tuesday, June 30th. Finally, New Street Research raised their target price on Lam Research from $235.00 to $280.00 and gave the stock a "neutral" rating in a research report on Monday, April 27th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $358.47.
View Our Latest Research Report on Lam Research
Lam Research Price Performance
Shares of NASDAQ:LRCX opened at $327.92 on Wednesday. Lam Research Corporation has a 12 month low of $94.11 and a 12 month high of $438.50. The firm has a market capitalization of $410.33 billion, a P/E ratio of 56.93, a P/E/G ratio of 1.32 and a beta of 1.84. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.63 and a quick ratio of 1.91. The company's fifty day moving average price is $339.86 and its 200 day moving average price is $284.93.
Lam Research (NASDAQ:LRCX - Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.69 by $0.13. The company had revenue of $6.72 billion during the quarter, compared to the consensus estimate of $6.66 billion. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. Lam Research's revenue for the quarter was up 30.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.33 earnings per share. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, sell-side analysts predict that Lam Research Corporation will post 9.32 earnings per share for the current fiscal year.
Lam Research Profile
(
Free Report)
Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
